跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AXCEL CETIRIZINE SYRUP 5MG/5ML - HSA Drug Approval Details
Approvals
/
HSA
/
AXCEL CETIRIZINE SYRUP 5MG/5ML
Approved
THERAPEUTIC
AXCEL CETIRIZINE SYRUP 5MG/5ML
KOTRA PHARMA (M) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Dec 4, 2014
Approval ID
5de008738b2f7876
Company
KOTRA PHARMA (M) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
5de008738b2f7876
Drug Name
AXCEL CETIRIZINE SYRUP 5MG/5ML
Product Name
AXCEL CETIRIZINE SYRUP 5MG/5ML
Approval Number
SIN14690P
Approval Date
2014-12-04
Registrant
KOTRA PHARMA MARKETING
Licence Holder
KOTRA PHARMA MARKETING
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
LIQUID
Route Of Administration
ORAL
Atc Code
R06AE07
Atc Item Name
cetirizine
Pharma Manufacturer Name
KOTRA PHARMA MARKETING
Company Detail Path
/organization/kotra-pharma-marketing
Active Ingredients
CETIRIZINE DIHYDROCHLORIDE
5MG/5ML
CETIRIZINE DIHYDROCHLORIDE
5 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 4, 2014
Approval ID
5de008738b2f7876
Type
Therapeutic
Back to HSA Approvals